FindTrial
Sign In

Non-invasive markers for early diagnosis and evaluation of the severity of necrotizing enterocolitis:The value of monitoring fecal high mobility group protein B1

Non-invasive markers for early diagnosis and evaluation of the severity of necrotizing enterocolitis:The value of monitoring fecal high mobility group protein B1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13005121
Enrollment
Unknown
Registered
2013-02-13
Start date
2013-07-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal necrotizing enterocolitis

Interventions

Gold Standard:
Index test:

Sponsors

Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria of observation group: Patients with clinical suspicion of NEC are included primarily in this study. Inclusion criteria of control group: Patients without NEC (including Suspected NEC) are included primarily in this study.

Exclusion criteria

Exclusion criteria: Patients with congenital intestinal malformations, including Congenital intestinal atresia, Hirschsprung's disease, intestinal malrotation will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
high mobility group box-1 protein;—

Secondary

MeasureTime frame
WBC;Plt;I/T;CRP;—

Countries

China

Contacts

Public ContactLi Luquan
liluquan123@163.com+86 13678433408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026